Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...

Personalized medicine is a therapeutic approach involving the use of an individual’s genetic and epigenetic information to tailor drug therapy or preventive care. We developed an endothelial ...

The Race and Medicine collection reflects NEJM’s commitment to understanding and combating racism as a public health and human rights crisis. Our commitment to antiracism includes efforts to ...

The discussions emphasised the evolving landscape of acute liver failure, sepsis in chronic liver disease, and post-transplant critical care The Tribune, now published from Chandigarh, started ...

Zydus Lifesciences has launched VaxiFlu-4, India’s first quadrivalent flu vaccine to offer better protection against influenza A and B strains. Experts stress the importance of vaccination and ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against a new strain of influenza virus. The company is introducing the country’s first flu protection quadrivalent ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...

Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced research and development efforts, Zydus Lifesciences Chairman Pankaj R Patel said on Friday.

Zydus Lifesciences Chairman Pankaj R Patel believes India can deliver 100 new drugs by 2047, emphasizing the need for innovation and societal benefit. Read more. New Delhi, Feb 21 (PTI) Indian pharma ...

and Zydus Lifesciences hit their 52-week lows in intraday trade on BSE on Wednesday, February 19, on the backdrop of conflicting global signals and uncertainties regarding the US tariffs that were ...